Upon completion of the educational activity, participants should be able to:

Cardiogenic Shock 2025: From SUSPECT to Solutions 

• Identify current evidence-based strategies for the early recognition and diagnosis of cardiogenic shock. 
• Compare contemporary approaches to hemodynamic support and multidisciplinary shock management. 
• Apply current evidence to improve outcomes for patients with cardiogenic shock. 

Seeing is Believing: CT-Guided Planning from Pixels to Procedures

• Evaluate the role of computed tomography (CT) imaging in the assessment and treatment planning of patients undergoing cardiovascular interventions.

The Contemporary CTEPH Toolbox: Integrating BPA Into Multidisciplinary Care 

• Describe current treatment options for chronic thromboembolic pulmonary hypertension (CTEPH). 
• Evaluate patient selection criteria for balloon pulmonary angioplasty (BPA).
• Incorporate multidisciplinary management strategies into the care of patients with CTEPH. 

Irwin R. Callen Memorial Lectureship: Right on Time—Rediscovering the Right Ventricle 

• Review the role of right ventricular structure and function in cardiovascular disease. 
• Interpret current diagnostic approaches to right ventricular assessment. 
• Integrate right ventricular evaluation into clinical decision-making. 

Hormones and the Heart: Navigating Cardiovascular Risk in Perimenopausal Women 

• Recognize cardiovascular risk factors unique to perimenopausal women. 
• Discuss the impact of hormonal changes on cardiovascular health. 
• Apply evidence-based strategies to reduce cardiovascular risk in women during midlife.

Cross-Atlantic Perspectives: AICD Policy Insights From Spain 

• Compare international approaches to implantable cardioverter-defibrillator (ICD) utilization. 
• Discuss healthcare policy factors that influence device therapy. 
• Identify opportunities to improve evidence-based ICD implementation. 

Aortic Function in Thoracic Aortic Aneurysms: Because the Aorta Is Not Just a Pipe 

• Describe the relationship between aortic function and thoracic aortic aneurysm progression. 
• Interpret emerging diagnostic methods for evaluating aortic disease. 
• Apply current evidence to optimize management of patients with thoracic aortic aneurysms. 

Structural Valve Intervention in 2026: Decision-Making in the Gray Zones 

• Evaluate patient selection for transcatheter valve interventions. 
• Compare treatment strategies for multivalvular heart disease. 
• Integrate guideline-directed medical therapy with structural heart interventions. 

Sociedad Española de Cardiología & FCACC Joint Session 

• Review evidence supporting first-line atrial fibrillation ablation. 
• Apply current lipid management recommendations for primary prevention. 
• Compare optimal medical therapy and revascularization strategies for stable coronary artery disease. 

Cardio-Oncology 

• Recognize cardiovascular complications associated with cancer therapies. 
• Apply multidisciplinary strategies for cardiovascular risk assessment in oncology patients. 
• Develop evidence-based management plans using case-based learning. 

EP Summit 

• Interpret complex electrophysiology cases using current evidence. 
• Evaluate emerging technologies and procedural approaches in cardiac electrophysiology. 
• Apply advanced ECG interpretation to challenging clinical scenarios. 

Not All Thick Hearts are the Same: Clinical Challenges Across the Spectrum of HCM and Cardiac Amyloidosis

• Differentiate the diagnostic, therapeutic, and disease-monitoring considerations for patients with hypertrophic cardiomyopathy (HCM) and cardiac amyloidosis to support evidence-based clinical management.

Translational Research

• Evaluate emerging translational research advances in cardiovascular disease.

Women Cardiologists: Own Your Narrative—Social Media Strategies for Women in Cardiology 

• Describe best practices for professional engagement on social media. 
• Identify strategies for effective professional branding and advocacy. 
• Utilize digital platforms to enhance education, networking, and leadership opportunities. 

EKG in the Athlete: From Physiology to Policy—Navigating Florida's New Requirements 

• Differentiate physiologic from pathologic ECG findings in athletes. 
• Apply current recommendations for cardiovascular screening of athletes. 
• Interpret Florida's evolving requirements for athletic ECG evaluation. 

When Winds Rise, So Do Heart Risks: Hurricanes and Heart Disease 

• Describe the cardiovascular impact of natural disasters. 
• Identify vulnerable patient populations during disaster events. 
• Develop preparedness strategies to improve cardiovascular care during emergencies. 

Beyond the Basics: Practical Insights from the 2025 ACHD Guidelines 

• Summarize key updates from the 2025 Adult Congenital Heart Disease guidelines. 
• Apply guideline recommendations to common adult congenital heart disease scenarios. 
• Optimize longitudinal care for adults with congenital heart disease. 

Great Debate: GLP-1 Receptor Agonists Are Cardiovascular Medications and Should Be Initiated by Cardiologists for Secondary Prevention 

• Review current evidence supporting GLP-1 receptor agonists for cardiovascular risk reduction. 
• Compare differing perspectives regarding clinician responsibility for initiating therapy. 
• Incorporate shared decision-making when considering GLP-1 receptor agonists for secondary prevention. 

FL-QUIC Oral Presentations 

• Evaluate quality improvement initiatives designed to improve cardiovascular care. 
• Apply evidence-based strategies to optimize heart failure management and appropriate imaging utilization. 
• Identify opportunities to implement quality improvement initiatives within their own practice. 

FIT Oral Presentations 

• Assess emerging cardiovascular research presented by Fellows in Training. 
• Discuss the impact of social media and epidemiologic trends on cardiovascular care. 
• Translate novel research findings into future clinical practice and investigation.
   

Commercial Support
There is no commercial support for this activity.